Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
VXGN.OB > SEC Filings for VXGN.OB > Form 8-K on 8-Jul-2008All Recent SEC Filings

Show all filings for VAXGEN INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for VAXGEN INC


8-Jul-2008

Entry into a Material Definitive Agreement, Financial Statements and Exhibits


Item 1.01. Entry into a Material Definitive Agreement.

Note Repurchase Agreements

On July 1, 2008, VaxGen Inc. ("VaxGen") entered into a Note Repurchase Agreement (the "Alexandra Agreement") with Alexandra Global Master Fund Ltd. ("Alexandra"), as amended on July 7, 2008 (the "Amendment"), whereby VaxGen agreed to repurchase two of its 5 1/2% convertible senior subordinated notes due April 2010 ("Notes") in an aggregate principal amount of $11,000,000 at a purchase price of $9,020,000, plus accrued interest of $163,013.35, based on an assumed settlement date of July 8, 2008.

On July 3, 2008, VaxGen entered into Note Repurchase Agreements with Whitebox Convertible Arbitrage Partners, LP (the "Whitebox Agreement") and Guggenheim Portfolio Company XXXI, LLC (the "Guggenheim Agreement"). Pursuant to the Whitebox Agreement, VaxGen agreed to repurchase its Notes in the principal amount of $8,350,000 at a purchase price of $6,847,000, plus accrued interest of $123,741.93, based on an assumed settlement date of July 8, 2008. Pursuant to the Guggenheim Agreement, VaxGen agreed to repurchase its Note in the principal amount of $650,000 at a purchase price of $533,000, plus accrued interest of $9,633.07, based on an assumed settlement date of July 8, 2008.

VaxGen has not initiated any broader effort to repurchase or restructure its remaining Notes.

The Alexandra Agreement, the Amendment, the Whitebox Agreement, and the Guggenheim Agreement are attached to this report as Exhibit 10.1, 10.2, 10.3, and 10.4, respectively (the "Agreements"). The foregoing descriptions are qualified in their entirety by reference to the full text of the Agreements.



Item 9.01. Financial Statements and Exhibits.

Exhibit
Number                                    Description

10.1         Note Repurchase Agreement, dated July 1, 2008, by and between VaxGen,
             Inc. and Alexandra Global Master Fund Ltd.

10.2         Amendment No. 1 to Note Repurchase Agreement, dated July 7, 2008 by
             and between Alexandra Global Master Fund Ltd. and VaxGen, Inc.

10.3         Note Repurchase Agreement, dated July 3, 2008, by and between VaxGen,
             Inc. and Whitebox Convertible Arbitrage Partners, LP

10.4         Note Repurchase Agreement, dated July 3, 2008, by and between VaxGen,
             Inc. and Guggenheim Portfolio Company XXXI, LLC


  Add VXGN.OB to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for VXGN.OB - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.